Unibest
← Back to patent-cliff list

CAS 142885-92-5

4-methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)thio)methyl)-3,5-dimethylpyridine 1-oxide

Codes: OMEP-006

Application context (from source-drug indications)

Helicobacter pylori infectionAmoxicillin/Omeprazole/RifabutinDyspepsiaAmoxicillin/Omeprazole/RifabutinGastric ulcerCinitapride Tartrate/OmeprazoleGastro-oesophageal reflux diseaseCinitapride Tartrate/OmeprazoleDyspepsiaCinitapride Tartrate/OmeprazoleHeartburnOmeprazoleGastro-oesophageal reflux diseaseOmeprazoleGastric ulcerOmeprazoleHyperacidityOmeprazoleDuodenal ulcerOmeprazoleHelicobacter pylori infectionOmeprazole

Source drugs (routes using this intermediate)

DrugTierExpiry
Amoxicillin/Omeprazole/RifabutinTier C — Watch / trade-
Cinitapride Tartrate/OmeprazoleTier C — Watch / trade-
OmeprazoleTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Amoxicillin/Omeprazole/RifabutinOptimised routesteps: 1total yield: 10 mg (Omeprazole)
4-methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)thio)methyl)-3,5-dimethylpyridine 1-oxide
Cinitapride Tartrate/OmeprazoleOptimised routesteps: 1total yield: 10 mg (Omeprazole)
4-methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)thio)methyl)-3,5-dimethylpyridine 1-oxide
OmeprazoleOptimised routesteps: 1total yield: 10 mg (Omeprazole)
4-methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)thio)methyl)-3,5-dimethylpyridine 1-oxide

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.